BOSTON , Sept. 18, 2024 /PRNewswire/ -- Meirowitz & Wasserberg is proud to announce a groundbreaking verdict in favor of Bryce and Diane Zundel , against Cimbar Performance Minerals. On September 13, 2024 , in a first-of-its-kind compelling talc trial that showcased the expertise and dedication of our legal team, a Boston jury awarded the Zundels a total of $39,081,142.
00 . The award includes: $3,000,000.00 for Bryce's past pain and suffering $21,500,000.
00 for Bryce's future pain and suffering $1,500,000.00 for Diane's past loss of consortium $10,750,000.00 for Diane's future loss of consortium $925,000.
00 for past medical expenses $925,000.00 for future medical expenses $481,142.00 in economic damages This landmark verdict comes in the wake of Bryce Zundel's tragic diagnosis of biphasic malignant mesothelioma, which followed his medical provider's use of "Sterile Talc Powder" in a talc pleurodesis procedure years earlier.
Despite the FDA approval of the talc used in the 2014 procedure, attorney investigations revealed that the talc supplied by Cimbar contained asbestos, leading to Bryce's diagnosis of mesothelioma, a condition which Cimbar acknowledged at trial would be terminal for Mr. Zundel. The trial team, led by the uniquely talented Danny R.
Kraft of Meirowitz & Wasserberg, achieved this significant verdict through relentless advocacy and strategic litigation. Mr. Kraft handled opening arguments, closing arguments, and every single witness that was a part of the trial.